Allograft immune response with sCR1 intervention

Transplant Immunology

Volumn 4, Issue 1, 1996, Pages 72-75

  Pratt, J R ^a   Hibbs, M J ^b   Laver, A J ^b   Smith, R A G ^b   Sacks, Steven ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT MEMBRANE ATTACK COMPLEX;

ANIMAL EXPERIMENT; ANIMAL TISSUE; B LYMPHOCYTE; BLOOD VESSEL INJURY; CELL MEDIATED CYTOTOXICITY; CONFERENCE PAPER; CONTROLLED STUDY; FLOW CYTOMETRY; GRAFT REJECTION; HISTOPATHOLOGY; KIDNEY ALLOGRAFT; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE;

EID: 0029977650     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(96)80041-4     Document Type: Conference Paper

References (30)

1. Feucht HE. Felber E, Gokel MJ et al. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 1991; 86: 464-70.
2. Arvicux J, Yssel H, Colomb MG. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones. Immunology 1988; 65: 229-35.
3. Erdei A, Spaeth E, Alsenz J et al. Role of C3b receptors in the enhancement of interleukin-2-dependent T-cell proliferation. Mol Immunol 1984; 21: 1215-21.
4. Burdick JF, Beschorner WE. Smith WJ et al. Characteristics of early routine renal allograft biopsies. Transplantation 1984; 38: 679-84.
5. d'Ardenne AJ, Dunnill MS, Thompson JF, McWhinnie D, Wood RF, Morris PJ. Cyclosporin and real graft histology. J Clin Pathol 1986; 39: 145-51.
6. Neild GH, Taube DH, Hartley RB et al. Morphological differentiation between rejection and cyclosporin nephrotoxicity in renal allografts. J Clin Pathol 1986; 39: 152-59.
7. Gadd KJ, Reid KB. Importance of the integrity of the inter-heavychain disulphide bond of rabbit IgG in the activation of the alternative pathway of human complement by the F(ah′)2 region of rabbit IgG antibody in immune aggregates. Immunology 1981; 42: 75-82.
8. Levine RP, Dodds AW. The thioester bond of C3 [Review]. Curr Top Microbiol Immunol 1990; 153: 73-82.
9. Van Dam AP, Hack CE. Formation, of C3-IgG complexes in serum by aggregated IgG and by non-immunoglobulin activators of complement. Immunology 1987; 61: 105-10.
10. Law SK, Lichtenberg NA, Levine RP. Evidence for an ester linkage between the labile binding site of C3b and receplive surfaces. J Immunol 1979; 123: 1388-94.
11. Sim RB, Twose TM, Paterson DS, Sim E. The covalent-binding reaction of complement component C3. Biochem J 1981; 193: 115-27.
12. Takata Y, Tamura N, Fujita T, Interaction of C3 with antigen-antibody complexes in the process of stabilization of immune precipitates. J Immunol 1984; 132: 2531-37.
13. Lambris JD. The multifunctional role of C3. the third component of complement [Review]. Immunol Today 1988; 9: 387-93.
14. Reid KB, Day AJ. Structure-function relationships of the complement components [published erratum appears in Immunol Today 1989; 10: following 216] [see comments]. Immunol Today 1989; 10: 177-80.
15. Erdei A, Fust G, Gergely J. The rule of C3 in the immune response [Review]. Immunol Today 1991; 12: 332-37.
16. Weisman HF, Bartow T, Leppo MK et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990; 249: 146-51.
17. Homeister JW, Satoh PS. Kilgore KS, Lucchesi BR. Soluble complement receptor type 1 prevents human complement-mediated damage of the rabbit isolated heart. J Immunol 1993; 150: 1055-64.
18. Pruitt SK, Kirk AD, Bollinger RR et al. The effect of soluble complement receptor type 1 on hyperacute rejection of procine xenografts. Transplantation 1994; 57: 363-70.
19. Pruitt SK, Baldwin WM III. Marsh HC Jr et al. The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. Transplantation 1991; 52: 868-73.
20. Pruitt SK, Bollinger RR, The effect of soluble complement receptor type I on hyperacute allograft rejection. J Surg Res 1991; 50: 350-55.
21. Xia W, Fearon DT. Moore FD Jr. Schoen FJ, Ortiz F, Kirkman RL. Prolongation of guinea pig cardiac xenograft survival in rats by soluble human complement receptor type 1. Transplant Proc 1992; 24: 479-80.
22. Fabre J, Lim SH, Morris PJ. Renal transplantation in the rat: details of a technique. Aust NZ J Surg 1971; 41: 69-75.
23. Leventhal JR, Matas AJ. Sun LH et al. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model. Transplantation 1993; 56: 1-8.
24. Hsu SM. Raine L. Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-80.
25. Jacquier-Sarlin MR, Gabert FM, Villiers MB, Colomb MG. Modulation of antigen processing and presentation by covalently linked complement C3b fragment. Immunology 1995; 84: 164-70.
26. Tuveson DA, Ahearn JM, Matsumoto AK, Fearon DT. Molecular interactions of complement receptors on B lymphocytes; a CR1/CR2 complex distinct from the CR2/CD19 complex. J Exp Med 1991; 73: 1083-89.
27. Pepys MB, Brighton WD, Hewitt BE, Bryant DE, Pepys J. Complement in the induction of IgE antibody formation. Clin Exp Immunol 1977; 27: 397-400.
28. Melchers F, Erdei A, Corbel C, Leptin M, Schulz T, Dierich MP. Cell cycle control of activated, synchronized murine B lymphocytes - roles of macrophages and complement C3. Mol Immunol 1986; 23: 1173-76.
29. Wiersma EJ, Kinoshita T, Heyman B. Inhibition of immunological memory and T-independent humoral responses by monoclonal antibodies specific for murine complement receptors. Eur J Immunol 1991; 21: 2501-506.
30. Erdei A, Bajtay Z, Fabry Z, Sim RB, Gergely J. Appearance of acceptor-bound C3b on HLA-DR positive macrophages and on stimulated U937 cells; inhibition of Fc gamma-receptors by the covalently lixed C3 fragments. Mol Immunol 1988; 25: 295-303.